Morquio syndrome

Last revised by Daniel J Bell on 16 Apr 2024

Morquio syndrome (in older literature it is sometimes called Morquio-Brailsford syndrome) is an autosomal recessive mucopolysaccharidosis (MPS) type IV.

Incidence estimated at ~1:40,000.

Many cases present at ~2 years of age and have normal intelligence. Clinical features:

  • severe dwarfism (<4 foot)

  • joint laxity

  • corneal opacification/clouding

  • lymphadenopathy

  • progressive deafness

  • spinal kyphoscoliosis

  • prominent mandible and lower face 

  • short neck

It results from an excess of keratan sulphate due to a deficit in its degradation pathway. Keratan sulphate accumulates in various tissues inclusive of cartilage, the nucleus pulposus of the intervertebral discs and corneas.

  • short and wide tubular bones

  • metaphyseal flaring in long bones

  • multiple epiphyseal centers

  • wide metacarpals with proximal pointing of index to little finger

  • irregular carpal bones 

  • flattened proximal femoral epiphyses; risk of lateral subluxation and dislocation

  • coxa valga

  • genu valgum

  • anterior sternal bowing, increased AP chest diameter, wide ribs

Life expectancy ranges between 30-40 years. The most common cause of death is cervical myelopathy from C2 abnormality. Patients are also particularly vulnerable to respiratory infection.

Named after Luis Morquio, an Uruguayan pediatrician (1867-1935) published his first case in 1929 5. James Brailsford (1889-1961) 6 a renowned British radiologist made an important contribution to the understanding of the radiographic appearances of this condition, and also published his first case in 1929, independently of Morquio 8.

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.